Trio Housesp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-08-06
Share capital
5,000.00 PLN
Registered address
ul. Obrońców Tobruku 38/208, 01-494 Warszawa, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 1349 days for 2019), 1 not filed.

  • 2021not filed
  • 202025/06/2024
  • 201925/06/2024
  • 2018not filed
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Ewa Maria Onych – President of the Management Board
Urszula Grażyna Onych – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Ewa Maria Onychage 47
99$1,337.1299%
Others
1$13.511%

Beneficial owners

No beneficial owners recorded for the company Trio House.

Bank accounts

Was a VAT taxpayer from 2023-09-13 to 2026-03-23.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for SME access to finance — aid for start-ups
$65,528

Competitors

Name
MedicofarmaS.A.
Natur DayS.A.
Biotriosp. z o.o.
Nature's Voicesp. z o.o.
Pexon Polandsp. z o.o.
Munar PharmaS.A.
Bioresearch PharmaS.A.
Cefeasp. z o.o.
Auxilius PharmaS.A.
Grupa FinepharmS.A.

Change history

DateEvent
2022-11-10Address change
2018-11-23PKD change
2014-08-06Entered in the register

FAQ

Last updated: 2026-04-08